UCB's Global Corporate Website
Welcome to UCB in the United States

2022 UCB U.S. Sustainable Access and Pricing Transparency Report


At UCB, we have a fundamental commitment to enabling people living with severe diseases, their caregivers, and their families to live the lives they want. We innovate to deliver unique outcomes that help specific patients achieve their life goals, to create the best individual experience for them, and to ensure access for all patients who need our solutions in a way which is viable for patients, society and UCB.

Our approach to innovation has always kept patients at the center. Now in its second year, the UCB U.S. Sustainable Access and Pricing Transparency report continues to provide information to stakeholders about how we account for the value of our medicines as well as outline the actions we have taken to build a more sustainable system together. 

As part of our 2022 Integrated Annual Report, our 2022 U.S. Sustainable Access and Pricing Transparency report includes:


  • How we are leading efforts to achieve sustainable access in the U.S. healthcare system
  • How we deliver affordable access and account for value, including when pricing our medicines
  • Policy reform opportunities to build a sustainable system together




We are committed to working across the healthcare ecosystem – with patients, payers, providers, caregivers, and policymakers, to explore a broad range of value and support smarter spending in the healthcare ecosystem, while ensuring that patients are able to access and afford the next generation of transformative medicines.

Hear More from UCB on How we Approach Value